Skin is one of the most hormone-responsive organs we have, and GAHT remodels its behavior gradually over the first one to three years. The patterns are well-documented in the medical literature, but most consumer skincare content is built around cisgender skin and assumes a stable baseline. Anyone going through hormone therapy is on a moving baseline, and the routine has to move with it.
What follows is a practical guide. It’s not medical advice on hormone dosing or formulation, which is between you and your physician. It’s a skincare guide for the changes that come downstream of those medical decisions.
What estrogen does to skin
Estrogen reduces sebum production, often noticeably within the first three to six months of therapy. Skin that was oily before therapy starts feeling drier, sometimes uncomfortably so. The sebaceous glands physically shrink over time with sustained estrogen exposure, and the skin’s natural lipid production decreases.
Estrogen also softens skin texture. Pores look smaller (because less sebum is sitting in them), the skin’s surface feels finer, and the overall “male pattern” of thicker, more textured skin gradually softens. The change is most visible at month six to twelve, though it continues subtly for two to three years.
The downside is dryness and barrier sensitivity. The same drop in sebum that improves texture also means the skin’s natural barrier protection weakens. Many people on estrogen-based HRT develop dry patches, mild eczema, or barrier flares in the first year, especially if they keep using the same astringent or oil-control products they used pre-therapy.
What testosterone does to skin
Testosterone increases sebum production. This usually begins within the first three to four months of therapy and peaks at six to eighteen months. The shift can be significant: skin that was dry or balanced pre-therapy often becomes visibly oily, with enlarged pores and a higher rate of comedonal and inflammatory acne. Acne is the single most common skin-related complication of testosterone therapy, with most published surveys finding rates of 30 to 50 percent in the first two years.
Testosterone also thickens skin and increases facial and body hair. The skin texture becomes coarser, with a more visible pore structure on the forehead, nose, and chin. These changes are gradual and continue for two to three years before stabilizing at a new baseline.
The pattern matters: testosterone-driven acne is often worst between months six and eighteen, then improves somewhat as the skin reaches its new equilibrium. Some people clear without treatment; many need a structured acne approach during the peak window.
What helps on estrogen therapy
Switch to a richer moisturizer and a gentler cleanser early. The products that worked on oilier pre-therapy skin will strip the new baseline. A ceramide-based moisturizer twice a day, a non-foaming cream cleanser, and skipping any toner or astringent are the typical adjustments.
Daily SPF, applied generously. Estrogen-treated skin shows pigmentation more easily, and any sun damage that accumulates during the transition is harder to reverse later.
A gentle retinoid two to three nights a week, started after the first six months when the skin’s new texture has stabilized. Retinoids on dry, sensitized newly-feminized skin without barrier support cause more irritation than benefit, so the timing matters.
Niacinamide 5 percent in the morning supports the barrier and reduces redness. Our Microbiome Glow Serum works well here because it layers under SPF without pilling.
What helps on testosterone therapy
Anticipate acne. Start a preventative routine in month two or three, before the peak window. Salicylic acid 2 percent cleanser, niacinamide serum, adapalene 0.1 percent applied two or three nights a week, lightweight moisturizer with SPF in the morning. This routine doesn’t prevent all acne but it reduces severity and post-acne marking.
Treat acne early. Mild inflammatory acne in month six is easier to address than moderate-to-severe cystic acne in month twelve. Don’t wait. If OTC products aren’t keeping pace, see a dermatologist for prescription topicals or oral therapy. Spironolactone is generally contraindicated on testosterone (it’s anti-androgenic), so the medical options narrow to oral antibiotics, isotretinoin, and hormonal modulation that doesn’t conflict with the therapy goals.
Daily SPF. Increased sebum doesn’t reduce UV vulnerability, and post-inflammatory marks from acne are slower to fade with increased sun exposure.
The contrarian view: don’t replicate your pre-therapy routine
One of the most common mistakes is sticking with a routine that worked pre-therapy out of familiarity. The routine that suited oily skin in your twenties won’t suit drier skin on estrogen at thirty-five, and vice versa. The routine has to follow the current behavior of your skin, not its history.
The other common mistake is adding too many actives at once, especially in response to a new acne pattern on testosterone or a new dry patch on estrogen. Add one product at a time, wait four to six weeks, then assess. Stacking salicylic acid, benzoyl peroxide, retinoid, and a clay mask in the same week on newly-transitioning skin is a fast route to barrier damage.
What the numbers say
A 2020 review in the Journal of the American Academy of Dermatology synthesized data from multiple GAHT cohort studies and reported that 33 to 47 percent of patients on masculinizing therapy develop clinically significant acne in the first two years, with peak incidence at 6 to 12 months. The same review reported sebum production drops of 35 to 50 percent over twelve months in patients on feminizing therapy, with corresponding increases in xerosis (dryness) and barrier sensitivity. The Endocrine Society’s 2017 clinical practice guideline on gender-dysphoric care specifically addresses cutaneous side effects as expected and treatable, recommending dermatologic referral when acne is moderate or severe.
When to see a dermatologist
See a derm if acne on testosterone therapy is moderate to severe by month four (large painful lesions, multiple cysts, visible scarring starting), if you have an eczema or barrier flare on estrogen therapy that doesn’t improve with gentle products in six to eight weeks, if you have unexplained hair loss or thinning beyond what your endocrinologist expects, or if pigmentation changes have appeared rapidly. A dermatologist who works with trans patients regularly is worth seeking out, since the standard acne protocols sometimes need adjustment around hormone goals.
The cost of waiting on testosterone-related acne is scarring. Cystic acne in the first two years of therapy is one of the more common preventable causes of long-term facial scarring in young trans men, and earlier intervention with prescription therapy markedly reduces that risk.
FAQ
How quickly will my skin change? First noticeable changes in three to six months. Major changes by year one. New stable baseline by year two to three.
Can I use the same SPF I always have? Probably, with adjustments. People on estrogen therapy often want a more hydrating SPF format. People on testosterone often want a lighter, oil-controlling format. The active ingredient itself stays the same.
Will retinoids cause more problems on testosterone-induced acne? Usually no, they help. Adapalene is well-tolerated and reduces both existing acne and new lesion formation. Tretinoin is also fine. The barrier sensitivity that affects estrogen-treated skin is less of an issue here.
Should I see a dermatologist or my hormone provider for skin issues? Both, ideally. Coordinate care. Hormone providers handle dosing and medical context. Dermatologists handle prescription topicals, procedural treatment, and acne management.
Will my skin go back to normal if I stop hormone therapy? Mostly, over a similar timeline. The changes are largely reversible, though some texture and pore changes from prolonged testosterone exposure may persist.
Related reading: hormonal acne: when skincare isn’t enough, barrier repair for sensitized skin, and cystic acne and prescription treatment.
Filed under hormonal acne, hormonal cycle, sensitive, skin science.
Sources
Hembree WC et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons. Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 2017. Wierckx K et al. Cross-sex hormone therapy in trans persons is safe and effective at short-term follow-up. Journal of Sexual Medicine, 2014. Yeung H, Luk KM. Dermatologic conditions in transgender patients. JAAD.org/” rel=”noopener” target=”_blank”>Journal of the AAD.org/” rel=”noopener” target=”_blank”>American Academy of Dermatology, 2020.